关键词: Apoptotic extracellular vesicles Lung adenocarcinoma Proteomics SOX2 Stemness

来  源:   DOI:10.1016/j.bioactmat.2024.02.026   PDF(Pubmed)

Abstract:
Apoptosis has long been recognized as a significant mechanism for inhibiting tumor formation, and a plethora of stimuli can induce apoptosis during the progression and treatment of tumors. Moreover, tumor-derived apoptotic extracellular vesicles (apoEVs) are inevitably phagocytosed by live tumor cells, promoting tumor heterogeneity. Understanding the mechanism by which apoEVs regulate tumor cells is imperative for enhancing our knowledge of tumor metastasis and recurrence. Herein, we conducted a series of in vivo and in vitro experiments, and we report that tumor-derived apoEVs promoted lung adenocarcinoma (LUAD) metastasis, self-renewal and chemoresistance. Mechanistically, we demonstrated that apoEVs facilitated tumor metastasis and stemness by initiating the epithelial-mesenchymal transition program and upregulating the transcription of the stem cell factor SOX2. In addition, we found that ALDH1A1, which was transported by apoEVs, activated the NF-κB signaling pathway by increasing aldehyde dehydrogenase enzyme activity in recipient tumor cells. Furthermore, targeting apoEVs-ALDH1A1 significantly abrogated these effects. Collectively, our findings elucidate a novel mechanism of apoEV-dependent intercellular communication between apoptotic tumor cells and live tumor cells that promotes the formation of cancer stem cell-like populations, and these findings reveal that apoEVs-ALDH1A1 may be a potential therapeutic target and biomarker for LUAD metastasis and recurrence.
摘要:
细胞凋亡一直被认为是抑制肿瘤形成的重要机制,在肿瘤的进展和治疗过程中,过多的刺激可以诱导细胞凋亡。此外,肿瘤衍生的凋亡细胞外囊泡(apoEV)不可避免地被活肿瘤细胞吞噬,促进肿瘤异质性。了解apoEV调节肿瘤细胞的机制对于增强我们对肿瘤转移和复发的认识至关重要。在这里,我们进行了一系列的体内和体外实验,我们报道肿瘤来源的apoEV促进肺腺癌(LUAD)转移,自我更新和化学抗性。机械上,我们证明apoEV通过启动上皮-间质转化程序和上调干细胞因子SOX2的转录促进肿瘤转移和干性.此外,我们发现由apoEV运输的ALDH1A1,通过增加受体肿瘤细胞的醛脱氢酶活性激活NF-κB信号通路。此外,靶向apoEVs-ALDH1A1显著消除了这些影响。总的来说,我们的发现阐明了凋亡肿瘤细胞和活肿瘤细胞之间依赖apoEV的细胞间通讯的新机制,该机制促进了癌症干细胞样群体的形成。这些发现表明,apoEVs-ALDH1A1可能是LUAD转移和复发的潜在治疗靶点和生物标志物。
公众号